Pedram Zohrevand, PhD

Zohrevand, Pedram 3672826_4003672826 TP

Title: Director
Company: CES4
Location: Woodland Hills, California, United States

Pedram Zohrevand, PhD, Director of CES4, has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in engineering and project management.

Dr. Zohrevand is a highly acclaimed professional engineer who has served as director of engineering for CES4 since 2014. Alongside this appointment, he has also acted as an adjunct professor and research assistant professor at Florida International University since 2012, as well as an instructor in strengthening and rehabilitation of bridges using advanced composites since 2013.

As a research scholar, Dr. Zohrevand developed the first steel-free concrete structure system for high seismic regions and the first constitutive model for confined ultra-high performance concrete. A prolific author, he has published more than 20 scholarly papers in esteemed journals with more than 100 citations in accordance with Google Scholar. Notably, he was the director for engineering design of a sustainable four-story office building in Miami, FL, the largest building in the United States made entirely of shipping containers.

To prepare for his career, Dr. Zohrevand earned a Bachelor of Science in 2004 and a Master of Science in civil engineering in 2007 from Isfahan University of Technology in Iran. He relocated to Florida International University in 2012, graduating with a Doctor of Philosophy in civil engineering. He has since been certified in project management and professional engineering. In recognition of his exceptional contributions to the engineering industry, he was named an Outstanding Doctoral Student and World’s Ahead Graduate by Florida International University in 2012. In addition, he was selected for inclusion in several editions of Who’s Who in America, Who’s Who in Medicine and Healthcare, Who’s Who in Science and Engineering, Who’s Who in the East, and Who’s Who in the World.

For more:

Press Release

Contact Dr. Zohrevand

Leave a Reply